MarketCap
Facebook
X
TelegramOxford Immunotec Global PLC DSO Ratio 2011-2026 | OXFD
Annual DSO Ratio Oxford Immunotec Global PLC
| 2020 | 2019 | 2018 | 2017 | 2016 | 2015 | 2014 | 2013 | 2012 | 2011 |
|---|---|---|---|---|---|---|---|---|---|
| - | 90.8 | 83.4 | 60.1 | 56.2 | 41 | 50.3 | 44.7 | - | - |
All numbers in USD currency
Indicator range from annual reports
| Maximum | Minimum | Average |
|---|---|---|
| 90.8 | 41 | 60.9 |
DSO Ratio of other stocks in the Diagnostics research industry
| Issuer | DSO Ratio | Price | % 24h | Market Cap | Country | |
|---|---|---|---|---|---|---|
 |
Centogene N.V.
CNTG
|
145 | - | -6.23 % | $ 30.6 M |  Germany |
 |
Burning Rock Biotech Limited
BNR
|
31.7 | $ 19.89 | 10.93 % | $ 211 M |  China |
 |
Agilent Technologies
A
|
63.8 | $ 120.39 | 2.46 % | $ 36.6 B |  USA |
 |
Aspira Women's Health
AWH
|
1.17 K | - | -6.19 % | $ 10.5 M | USA |
 |
Biocept
BIOC
|
112 | - | -13.05 % | $ 7.29 M | USA |
 |
Chembio Diagnostics
CEMI
|
66.3 | - | 0.22 % | $ 16.8 M | USA |
 |
CareDx, Inc
CDNA
|
51.5 | $ 17.63 | 4.75 % | $ 939 M | USA |
 |
DermTech
DMTK
|
80.6 | - | -11.32 % | $ 2.94 M | USA |
|
Akumin
AKU
|
57.4 | - | -17.87 % | $ 25.9 M |  Canada |
 |
Enzo Biochem
ENZ
|
50.3 | - | -8.98 % | $ 14.8 K | USA |
 |
Co-Diagnostics
CODX
|
94.7 | $ 1.38 | -4.83 % | $ 1.84 M | USA |
 |
Exact Sciences Corporation
EXAS
|
30.8 | - | - | $ 19.8 B | USA |
 |
Accelerate Diagnostics
AXDX
|
291 | - | -61.36 % | $ 2.46 M | USA |
 |
Castle Biosciences
CSTL
|
49.2 | $ 24.37 | 3.57 % | $ 677 M | USA |
 |
Global Cord Blood Corporation
CO
|
112 | - | - | $ 399 M | China |
 |
Fluidigm Corporation
FLDM
|
67.2 | - | 1.08 % | $ 308 M | USA |
 |
Genetic Technologies Limited
GENE
|
11.7 K | - | - | $ 7.1 B |  Australia |
 |
Genetron Holdings Limited
GTH
|
122 | - | 0.12 % | $ 80.1 M | China |
 |
Charles River Laboratories International
CRL
|
65 | $ 179.31 | 0.54 % | $ 8.89 B | USA |
 |
PRA Health Sciences, Inc.
PRAH
|
98.1 | - | - | $ 10.7 B | USA |
 |
Interpace Biosciences
IDXG
|
66.9 | $ 2.2 | - | $ 9.73 M | USA |
 |
Danaher Corporation
DHR
|
55.3 | $ 198.61 | 1.4 % | $ 142 B | USA |
 |
Heska Corporation
HSKA
|
40.8 | - | - | $ 1.31 B | USA |
 |
HTG Molecular Diagnostics
HTGM
|
101 | - | -20.0 % | $ 1.06 M | USA |
 |
Illumina
ILMN
|
61.3 | $ 130.32 | 2.65 % | $ 20.7 B | USA |
 |
Medpace Holdings
MEDP
|
50.4 | $ 520.0 | 3.74 % | $ 15 B | USA |
 |
Fulgent Genetics
FLGT
|
77.4 | $ 16.02 | 4.71 % | $ 484 M | USA |
 |
Motus GI Holdings
MOTS
|
77.2 | - | -34.28 % | $ 263 K |  Israel |
 |
Guardant Health
GH
|
46.1 | $ 86.4 | 5.1 % | $ 10.8 B | USA |
 |
QIAGEN N.V.
QGEN
|
30.8 | - | - | $ 10.6 B |  Niderland |
 |
Myriad Genetics
MYGN
|
52.3 | $ 4.91 | 6.97 % | $ 455 M | USA |
 |
Anixa Biosciences
ANIX
|
275 | $ 2.88 | 1.05 % | $ 93.5 K | USA |
 |
Biomerica
BMRA
|
57.7 | $ 2.1 | 0.96 % | $ 4.82 M | USA |
 |
Senseonics Holdings
SENS
|
10.3 | $ 6.75 | 0.45 % | $ 282 M | USA |
 |
ICON Public Limited Company
ICLR
|
68.5 | $ 113.06 | 2.44 % | $ 9.33 B |  Irlanda |
 |
NeoGenomics
NEO
|
77.7 | $ 8.35 | 4.38 % | $ 1.07 B | USA |
 |
Laboratory Corporation of America Holdings
LH
|
52.9 | $ 268.87 | 1.78 % | $ 22.4 B | USA |
 |
Neogen Corporation
NEOG
|
66.6 | $ 9.61 | 5.14 % | $ 2.08 B | USA |
 |
Lantheus Holdings
LNTH
|
80.5 | $ 82.74 | 1.31 % | $ 5.58 B | USA |
 |
Quest Diagnostics Incorporated
DGX
|
44.9 | $ 194.16 | 0.65 % | $ 21.6 B | USA |
 |
Natera
NTRA
|
81.5 | $ 214.64 | 6.31 % | $ 21.1 B | USA |
 |
ENDRA Life Sciences
NDRA
|
7.11 | $ 4.96 | -4.43 % | $ 3.9 M | USA |
 |
Invitae Corporation
NVTA
|
242 | - | - | $ 21.2 M | USA |
 |
National Research Corporation
NRC
|
29.4 | $ 17.04 | 1.34 % | $ 381 M | USA |
 |
Organovo Holdings
ONVO
|
79.8 | - | -2.3 % | $ 19.4 M | USA |
 |
OpGen
OPGN
|
4.66 | - | -16.95 % | $ 1.54 M | USA |